Your browser doesn't support javascript.
loading
Sex specific associations in genome wide association analysis of renal cell carcinoma.
Laskar, Ruhina S; Muller, David C; Li, Peng; Machiela, Mitchell J; Ye, Yuanqing; Gaborieau, Valerie; Foll, Matthieu; Hofmann, Jonathan N; Colli, Leandro; Sampson, Joshua N; Wang, Zhaoming; Bacq-Daian, Delphine; Boland, Anne; Abedi-Ardekani, Behnoush; Durand, Geoffroy; Le Calvez-Kelm, Florence; Robinot, Nivonirina; Blanche, Helene; Prokhortchouk, Egor; Skryabin, Konstantin G; Burdett, Laurie; Yeager, Meredith; Radojevic-Skodric, Sanja; Savic, Slavisa; Foretova, Lenka; Holcatova, Ivana; Janout, Vladimir; Mates, Dana; Rascu, Stefan; Mukeria, Anush; Zaridze, David; Bencko, Vladimir; Cybulski, Cezary; Fabianova, Eleonora; Jinga, Viorel; Lissowska, Jolanta; Lubinski, Jan; Navratilova, Marie; Rudnai, Peter; Swiatkowska, Beata; Benhamou, Simone; Cancel-Tassin, Geraldine; Cussenot, Olivier; Trichopoulou, Antonia; Riboli, Elio; Overvad, Kim; Panico, Salvatore; Ljungberg, Borje; Sitaram, Raviprakash T; Giles, Graham G.
Afiliação
  • Laskar RS; International Agency for Research on Cancer (IARC), Lyon, France.
  • Muller DC; Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
  • Li P; Max Planck Institute for Demographic Research, Rostock, Germany.
  • Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Ye Y; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gaborieau V; International Agency for Research on Cancer (IARC), Lyon, France.
  • Foll M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Colli L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Wang Z; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Bacq-Daian D; Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.
  • Boland A; Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.
  • Abedi-Ardekani B; International Agency for Research on Cancer (IARC), Lyon, France.
  • Durand G; International Agency for Research on Cancer (IARC), Lyon, France.
  • Le Calvez-Kelm F; International Agency for Research on Cancer (IARC), Lyon, France.
  • Robinot N; International Agency for Research on Cancer (IARC), Lyon, France.
  • Blanche H; Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
  • Prokhortchouk E; Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation.
  • Skryabin KG; Kurchatov Scientific Center, Moscow, Russian Federation.
  • Burdett L; Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation.
  • Yeager M; Kurchatov Scientific Center, Moscow, Russian Federation.
  • Radojevic-Skodric S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Savic S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
  • Foretova L; Institute of Pathology, Medical school of Belgrade, Belgrade, Serbia.
  • Holcatova I; Department of Urology, University Hospital "Dr D. Misovic" Clinical Center, Belgrade, Serbia.
  • Janout V; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Mates D; 2nd Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.
  • Rascu S; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
  • Mukeria A; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
  • Zaridze D; National Institute of Public Health, Bucharest, Romania.
  • Bencko V; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
  • Cybulski C; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
  • Fabianova E; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
  • Jinga V; First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
  • Lissowska J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Lubinski J; Regional Authority of Public Health in BanskaBystrica, BanskaBystrica, Slovakia.
  • Navratilova M; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
  • Rudnai P; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Swiatkowska B; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Benhamou S; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Cancel-Tassin G; National Public Health Institute, Budapest, Hungary.
  • Cussenot O; Department of Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.
  • Trichopoulou A; INSERM U946, Paris, France.
  • Riboli E; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
  • Overvad K; Sorbonne Université, GRC no. 5, ONCOTYPE-URO, AP-HP, Tenon Hospital, Paris, France.
  • Panico S; CeRePP, Paris, France.
  • Ljungberg B; Sorbonne Université, GRC no. 5, ONCOTYPE-URO, AP-HP, Tenon Hospital, Paris, France.
  • Sitaram RT; CeRePP, Paris, France.
  • Giles GG; Hellenic Health Foundation, Alexandroupoleos 23, Athens, 11527, Greece.
Eur J Hum Genet ; 27(10): 1589-1598, 2019 10.
Article em En | MEDLINE | ID: mdl-31231134
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Predisposição Genética para Doença / Estudo de Associação Genômica Ampla / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Predisposição Genética para Doença / Estudo de Associação Genômica Ampla / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido